431 related articles for article (PubMed ID: 15242758)
21. Telomere length and radiosensitivity in human fibroblast clones immortalized by ectopic telomerase expression.
Zongaro S; Verri A; Giulotto E; Mondello C
Oncol Rep; 2008 Jun; 19(6):1605-9. PubMed ID: 18497972
[TBL] [Abstract][Full Text] [Related]
22. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects.
Kelland LR
Eur J Cancer; 2005 May; 41(7):971-9. PubMed ID: 15862745
[TBL] [Abstract][Full Text] [Related]
23. Effects of cisplatin on telomerase activity and telomere length in BEL-7404 human hepatoma cells.
Zhang RG; Zhang RP; Wang XW; Xie H
Cell Res; 2002 Mar; 12(1):55-62. PubMed ID: 11942411
[TBL] [Abstract][Full Text] [Related]
24. Clonal variation in phenotype and life span of human embryonic fibroblasts (MRC-5) transduced with the catalytic component of telomerase (hTERT).
Franco S; MacKenzie KL; Dias S; Alvarez S; Rafii S; Moore MA
Exp Cell Res; 2001 Aug; 268(1):14-25. PubMed ID: 11461114
[TBL] [Abstract][Full Text] [Related]
25. Reconstitution of active telomerase in primary human foreskin fibroblasts: effects on proliferative characteristics and response to ionizing radiation.
Kampinga HH; Van Waarde-Verhagen MA; Van Assen-Bolt AJ; Nieuwenhuis B; Rodemann HP; Prowse KR; Linskens MH
Int J Radiat Biol; 2004 May; 80(5):377-88. PubMed ID: 15223771
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.
Tárkányi I; Aradi J
Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408
[TBL] [Abstract][Full Text] [Related]
27. Telomere dysfunction and telomerase reactivation in human leukemia cell lines after telomerase inhibition by the expression of a dominant-negative hTERT mutant.
Delhommeau F; Thierry A; Feneux D; Lauret E; Leclercq E; Courtier MH; Sainteny F; Vainchenker W; Bennaceur-Griscelli A
Oncogene; 2002 Nov; 21(54):8262-71. PubMed ID: 12447689
[TBL] [Abstract][Full Text] [Related]
28. Telomeres and aging.
Aubert G; Lansdorp PM
Physiol Rev; 2008 Apr; 88(2):557-79. PubMed ID: 18391173
[TBL] [Abstract][Full Text] [Related]
29. Targeting telomeres and telomerase.
De Cian A; Lacroix L; Douarre C; Temime-Smaali N; Trentesaux C; Riou JF; Mergny JL
Biochimie; 2008 Jan; 90(1):131-55. PubMed ID: 17822826
[TBL] [Abstract][Full Text] [Related]
30. Ectopic mTERT expression in mouse embryonic stem cells does not affect differentiation but confers resistance to differentiation- and stress-induced p53-dependent apoptosis.
Lee MK; Hande MP; Sabapathy K
J Cell Sci; 2005 Feb; 118(Pt 4):819-29. PubMed ID: 15687103
[TBL] [Abstract][Full Text] [Related]
31. Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: effects of telomerase and oxidative stress.
Matthews C; Gorenne I; Scott S; Figg N; Kirkpatrick P; Ritchie A; Goddard M; Bennett M
Circ Res; 2006 Jul; 99(2):156-64. PubMed ID: 16794190
[TBL] [Abstract][Full Text] [Related]
32. Retroviral-mediated expression of telomerase in normal human cells provides a selective growth advantage.
Forsythe HL; Elmore LW; Jensen KO; Landon MR; Holt SE
Int J Oncol; 2002 Jun; 20(6):1137-43. PubMed ID: 12011990
[TBL] [Abstract][Full Text] [Related]
33. Telomeres and telomerase as targets for anticancer drug development.
Olaussen KA; Dubrana K; Domont J; Spano JP; Sabatier L; Soria JC
Crit Rev Oncol Hematol; 2006 Mar; 57(3):191-214. PubMed ID: 16469501
[TBL] [Abstract][Full Text] [Related]
34. Telomerase activity does not always imply telomere maintenance.
Ouellette MM; Aisner DL; Savre-Train I; Wright WE; Shay JW
Biochem Biophys Res Commun; 1999 Jan; 254(3):795-803. PubMed ID: 9920820
[TBL] [Abstract][Full Text] [Related]
35. Oxidative stress causes telomere damage in Fanconi anaemia cells - a possible predisposition for malignant transformation.
Uziel O; Reshef H; Ravid A; Fabian I; Halperin D; Ram R; Bakhanashvili M; Nordenberg J; Lahav M
Br J Haematol; 2008 Jul; 142(1):82-93. PubMed ID: 18477050
[TBL] [Abstract][Full Text] [Related]
36. Telomere length homeostasis requires that telomerase levels are limiting.
Cristofari G; Lingner J
EMBO J; 2006 Feb; 25(3):565-74. PubMed ID: 16424902
[TBL] [Abstract][Full Text] [Related]
37. Effects of telomerase modulation in human hematopoietic progenitor cells.
Zimmermann S; Glaser S; Ketteler R; Waller CF; Klingmüller U; Martens UM
Stem Cells; 2004; 22(5):741-9. PubMed ID: 15342938
[TBL] [Abstract][Full Text] [Related]
38. A mathematical model of cellular apoptosis and senescence through the dynamics of telomere loss.
Arkus N
J Theor Biol; 2005 Jul; 235(1):13-32. PubMed ID: 15833310
[TBL] [Abstract][Full Text] [Related]
39. Consequences of telomerase inhibition by BIBR1532 on proliferation and chemosensitivity of chondrosarcoma cell lines.
Parsch D; Brassat U; Brümmendorf TH; Fellenberg J
Cancer Invest; 2008 Jul; 26(6):590-6. PubMed ID: 18584350
[TBL] [Abstract][Full Text] [Related]
40. Structural stability and chromosome-specific telomere length is governed by cis-acting determinants in humans.
Britt-Compton B; Rowson J; Locke M; Mackenzie I; Kipling D; Baird DM
Hum Mol Genet; 2006 Mar; 15(5):725-33. PubMed ID: 16421168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
